PsychAD Consortium Maps 6.3 Million Brain Cells to Link Genetic Risk with Cellular Disease Mechanisms
A coordinated series of nine papers led by the PsychAD Consortium has released the largest single-cell transcriptomic atlas of the human brain to date. The primary study, published in Nature, analyzes over 6.3 million nuclei from 1,494 donors to map molecular changes across eight brain disorders, including Alzheimer’s, Parkinson’s, and schizophrenia. The research identifies shared cellular vulnerabilities across diseases, particularly in immune and vascular cells, while distinguishing specific signatures for neurodegenerative versus psychiatric conditions. Complementary studies link genetic risk variants to specific cell types and develop AI frameworks for personalized Alzheimer’s progression. The findings suggest that while many brain disorders share common molecular pathways, distinct cellular responses drive individual disease trajectories, offering new targets for therapeutic intervention.
